The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inherited defects in checkpoint kinase 2 (CHEK2) to confer increased susceptibility to testicular germ cell tumors.
 
Saud H. Aldubayan
No Relationships to Disclose
 
Louisa T Pyle
No Relationships to Disclose
 
Jennifer T. Loud
No Relationships to Disclose
 
Mark H. Greene
No Relationships to Disclose
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen Biotech (Inst); Sanofi (Inst); Sotio (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Katherine Nathanson
No Relationships to Disclose
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Genome Medical; Syapse; Tango Therapeutics
Consulting or Advisory Role - Genome Medical; InVitae; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis
 
Douglas R Stewart
No Relationships to Disclose
 
Davor Lessel
No Relationships to Disclose